Historically, most cervical surgeries result in fusion, which provides pain relief, but at a cost of loss of motion and higher risk of additional future surgeries. Recent clinical studies have shown that 4 years after cervical fusion, the risk of adjacent level degeneration is increased by nearly three-fold compared to disc replacement.
The Disc Replacement Center at Jordan Valley Medical Center offers an alternative—artificial disc replacement, which provides pain relief and preserves motion and function."
Learn how disc replacement improves range of motion.
Dr. Armen Khachatryan is a board-certified orthopedic surgeon specializing in minimally invasive microsurgery and the treatment of cervical and lumbar spinal disease.
In addition to broad training in many traditional spinal surgical options — such as decompression laminectomies and fusion — Dr. Khachatryan has extensive experience in minimally invasive surgery, motion preservation technology, artificial disc replacement and non-fusion technologies.
Dr Khachatryan has been a clinical investigator in a number of different FDA clinical trials, including a novel bioactive composite for vertebral fracture treatment and a pivotal FDA trial for Mobi-C cervical artificial disc replacement. After nearly six years of clinical trials, this device was approved by the FDA for clinical use in August 2013. Mobi-C is currently the only artificial disc replacement available in United States that has been approved by the FDA both for single and two level disc replacement surgery.